BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8642855)

  • 1. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
    Hu ZB; Minden MD; McCulloch EA
    Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
    Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA
    Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
    Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
    Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the synthesis of bcl-2 protein by growth factors.
    Hu ZB; Minden MD; McCulloch EA
    Leukemia; 1996 Dec; 10(12):1925-9. PubMed ID: 8946932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.
    Yang GS; Minden MD; McCulloch EA
    Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells.
    Hu ZB; Minden MD; McCulloch EA
    Leukemia; 1995 Oct; 9(10):1667-73. PubMed ID: 7564507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
    Yang GS; Minden MD; McCulloch EA
    Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity.
    Koistinen P; Wang C; Curtis JE; McCulloch EA
    Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor.
    Bradbury D; Zhu YM; Russell N
    Leukemia; 1994 May; 8(5):786-91. PubMed ID: 8182935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
    Tafuri A; Lemoli RM; Chen R; Gulati SC; Clarkson BD; Andreeff M
    Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
    Bergamaschi G; Cazzola M; Rosti V; Carlo-Stella C; Santini V; Ponchio L; Peverali FA; Della Valle G; Rossi Ferrini P; Ascari E
    Leukemia; 1991 Oct; 5(10):886-91. PubMed ID: 1961022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid.
    Imaizumi M; Sato A; Koizumi Y; Inoue S; Suzuki H; Suwabe N; Yoshinari M; Ichinohasama R; Endo K; Sawai T
    Leukemia; 1994 Aug; 8(8):1301-8. PubMed ID: 7520101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2.
    Hedley DW; McCulloch EA
    Leukemia; 1996 Jul; 10(7):1143-9. PubMed ID: 8683994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
    Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
    Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
    Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells.
    Mano Y; Shimizu T; Tanuma S; Takeda K
    Anticancer Res; 2000; 20(3A):1649-52. PubMed ID: 10928085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studies.
    Curtis JE; Minkin S; Minden MD; McCulloch EA
    Br J Haematol; 1996 Nov; 95(2):354-63. PubMed ID: 8904892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte macrophage colony-stimulating factor enhances retinoic acid-induced gene expression.
    Shimizu T; Esaki L; Mizuno H; Takeda K
    J Leukoc Biol; 2006 Oct; 80(4):889-96. PubMed ID: 16885501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.